What conditions does Miltenyi Biomedicine GmbH run trials for?

In our tracked recruiting trials, Miltenyi Biomedicine GmbH sponsors trials for Lupus, Systemic Lupus Erythematosus, Acute Lymphatic Leukemia.

Clinical trials sponsored by Miltenyi Biomedicine GmbH

Recruiting trials

Conditions studied

Phase 1 4Phase 2 3Not applicable 1

Condition	Trials
Lupus	3
Systemic Lupus Erythematosus	2
Acute Lymphatic Leukemia	1
B-cell Non Hodgkin Lymphoma	1
CAR T Cell Therapy	1
Childhood Non-Hodgkin Lymphoma	1
Chronic Lymphatic Leukemia	1
Dermatomyositis	1
Diffuse Cutaneous Systemic Sclerosis	1
Lupus Nephritis	1
Melanoma	1
Melanoma Stage III	1
Melanoma Stage IV	1
Multiple Sclerosis	1
Pediatric ALL	1

CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
NCT06347718 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
NCT06508775 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 7 locations
MB-CART19.1 in Refractory SLE
NCT06189157 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
MB-CART2019.1 in Refractory Multiple Sclerosis
NCT07178431 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
US Zamto-cel Autoimmune Diseases
NCT06708845 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location